PE Ultra mRNA, RG, 100 µg
Prime editing is a CRISPR-based genome editing modality that enables targeted DNA modifications without creating double-strand breaks or relying on donor DNA templates. Compared to traditional CRISPR-Cas9 editing, prime editing offers broader editing flexibility while reducing reliance on cellular DNA repair pathways.
Prime editing utilizes a prime editor enzyme and a prime editing guide RNA (pegRNA) that includes a primer binding site (PBS) and reverse transcription template (RTT), with programmable editing instructions encoded directly within the RTT of the pegRNA. This approach enables all base substitutions, small insertions, small deletions, and combination edits.
Enzymatically capped mRNA encoding PE Ultra Prime Editor (PE) in a eukaryotic expression context. Encodes an engineered S. pyogenes-derived nCas9 fused to an engineered reverse transcriptase. Contains 5' and 3' UTRs, Cap 1 structure, >100 nt polyA tail, nuclear localization sequences (NLS), and is fully N1-methylpseudouridine modified. Research-grade mRNA manufactured by Aldevron. Provided at 1 mg/mL in 1 mM sodium citrate buffer, pH 6.4.
Performance Highlights
- Create precise substitutions, insertions, and deletions from a single editing platform
- Edit without double-strand DNA breaks or donor templates
- Optimized prime editor mRNA designed for improved editing success with improved activity over current published variants
Product Data
Comparison of editing efficiency of PE Ultra mRNA to commercially available PEmax

Comparison of prime editing efficiency across dozens of genomic targets in HEK293 cells, showing higher NGS-measured editing rates for Aldevron’s PE Ultra mRNA versus commercial PEmax mRNA following nucleofection delivery.
Figure 1. Editing efficiency of PE Ultra and PEmax in HEK293 cells. PE Ultra and PEmax mRNA and Alt-R pegRNA (6 µM) targeting a broad panel of sites (all 6 bp insertions) were delivered by nucleofection into HEK293 cells using the Lonza Nucleofection™ System. Genomic DNA (gDNA) was extracted 72 hours post nucleofection and editing was assessed by NGS.
Visit the Prime Editing mRNA product page to learn more.
If you need to speak to an expert, please fill in the contact us form and a member of our team will reach out to you.